is contracted via the University of Liverpool (no personal payment) to undertake consultancy for Altimmune, AstraZeneca, Boehringer Ingelheim, Cytoki, Eli Lilly, Napp, Novo Nordisk, Menarini, Pfizer, Rhythm Pharmaceuticals, Sanofi, Saniona, Tern, Shionogi and Ysopia and declares personal honoraria/lecture fees from AstraZeneca, Boehringer Ingelheim, Medscape, Menarini, Napp, Novo Nordisk and Rhythm
If we have refunds agreements, you will be responsible for the return shipping charges
Learn more here: Medical Weight Loss: Is One Better Than the Other
SEMABEST represents a significant step forward in making complex peptide therapies more accessible, affordable, and scalable for Indian patients
This includes guidance on dietary modifications to mitigate gastrointestinal side effects and instructions on recognizing symptoms of serious adverse reactions